Rehabilitation program for patients with chronic diseases
Official title: The Bern Rehab Registry - a Prospective Cohort Study in Patients With Chronic Non-communicable Diseases Participating in a Comprehensive Rehabilitation Programme
Run by Insel Gruppe AG, University Hospital Bern · NCT06516172 · Data updated 2026-11-12
This study is testing a rehabilitation program to see if it helps people with long-term illnesses like cancer and heart disease feel better and improve their overall health.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 30000 (estimated) |
| Sponsor | Insel Gruppe AG, University Hospital Bern Academic / other |
| Locations | 2 sites (Heiligenschwendi, Canton of Bern and 1 other locations) |
| Status | Recruiting |
| Started | December 1, 2020 |
| Main results expected | December 2029 |
| Study ends | December 2030 |
| Registry record updated | August 19, 2024 |
| Trial ID | NCT06516172 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older with chronic non-communicable diseases who have been referred for rehabilitation.
✕Probably not a fit
Patients who do not provide informed consent or have acute medical conditions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study evaluates the health outcomes of patients with long-term illnesses such as cancer, cardiovascular, musculoskeletal, and pulmonary diseases who participate in a comprehensive rehabilitation program. The program may include inpatient stays, outpatient visits, or home-based care supported by digital health tools. Key health outcomes measured include physical fitness, body composition, and self-reported health metrics like anxiety and quality of life. The study aims to improve care quality and inform future research questions based on the outcomes observed.
Why it matters
Potential benefit: If successful, this program could enhance the physical and mental well-being of patients with chronic diseases, potentially reducing complications and improving quality of life.
How similar studies have gone: Other studies have shown positive outcomes with similar rehabilitation approaches, indicating potential for success in this program.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients aged 18 years and older with a chronic non-communicable disease * Signed general informed consent * Referral to a comprehensive disease-specific rehabilitation program Exclusion Criteria: * Refuted or missing general informed consent for further use of health-related data and samples.
Where it's running
-
Berner Reha Centre, Centre for Rehabilitation & Sports Medicine, Insel Group
Heiligenschwendi, Canton of Bern, Switzerland Recruiting -
Reha Inselspital, Bern University Hospital, Centre for Rehabilitation & Sports Medicine, Insel Group
Bern, Switzerland Recruiting
Study contacts
- Principal investigator: Matthias Wilhelm, MD — Centre for Rehabilitation & Sports Medicine, Insel Group
- Study coordinator: Matthias Wilhelm, MD
- Email: matthias.wilhelm@insel.ch
- Phone: +41 31 632 8986
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
100-Year Human Aging and Longevity Tracking Program
This project will follow adults over their lifetimes to see if repeated health tests can predict lifespan, causes of death, serious disease, and loss of function.
-
Building a multiomic database using advanced imaging techniques
This study is trying to build a big database using advanced imaging techniques to see how different health information can help better understand and prevent diseases in adult patients.
-
Abnormal menstrual bleeding in women on antithrombotic drugs after heart surgery
This study looks at whether women on blood thinners after heart surgery have abnormal menstrual bleeding and what factors might put some at higher risk.
-
AI-powered ECG to help diagnose and predict outcomes in heart disease
Researchers test an AI-enhanced ECG to help diagnose and predict outcomes for people with cardiovascular diseases.
-
Colchicine for preventing cardiovascular disease in adults with type 2 diabetes
A 24-week study will test whether low-dose colchicine can help protect blood vessels in adults with type 2 diabetes who have not yet developed artery disease, compared with a placebo.
-
Optimised Cardio-Renal Care for CKD and heart disease
This study tests whether a specialised Cardio-Renal Clinic can improve heart and kidney health and quality of life for adults with chronic kidney disease and cardiovascular disease.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.